Liver diseases in Mexico and their associated mortality trends from 2000 to 2007: A retrospective study of the nation and the federal states

Annals of Hepatology

Volumn 9, Issue 4, 2010, Pages 428-438

  Méndez Sánchez, Nahum ^a   García Villegas, Elsy ^b   Merino Zeferino, Beatriz ^b   Ochoa Cruz, Soledad ^b   Villa, Antonio R ^c   Madrigal, Herlinda ^b   Kobashi Margáin, Ramón A ^a   Gutiérrez Grobe, Ylse ^a   Chávez Tapia, Norberto ^a   Ponciano Rodríguez, Guadalupe ^d   Uribe, Misael ^a  

^a LIVER RESEARCH UNIT   (Mexico)

^b Salvador Zubiran National Institute of Medical Science and Nutrition   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^d UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Alcoholic liver disease; Cirrhosis; Liver related mortality; Malignant tumors; Viral hepatitis

Indexed keywords

ADULT; AGE; AGED; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; INFANT; LIVER CANCER; LIVER DISEASE; LIVER FIBROSIS; LIVER TUMOR; MAJOR CLINICAL STUDY; MALE; MEXICO; MORTALITY; POPULATION RISK; RETROSPECTIVE STUDY; TREND STUDY; VIRUS HEPATITIS; ADOLESCENT; CHILD; ETHNOLOGY; LIVER CIRRHOSIS; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; PREVALENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATITIS, VIRAL, HUMAN; HUMANS; INFANT; INFANT, NEWBORN; LIVER CIRRHOSIS; LIVER DISEASES; LIVER NEOPLASMS; MALE; MEXICO; MIDDLE AGED; MORTALITY; PREVALENCE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 79952278424     PISSN: 16652681     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1665-2681(19)31619-9     Document Type: Article

References (32)

1. SINAIS, Sistema Nacional de Información en Salud. Available at http://sinais.salud.gob.mx/mortalidad.
2. Méndez-Sánchez N, Villa AR, Chávez-Tapia NC, et al. Trends in liver disease prevalence in Mexico from 2005 to 2050 through mortality data. Ann Hepatol 2005; 4(1): 52-55.
3. Shepard BD, Fernandez DJ, Tuma PL. Alcohol consumption impairs hepatic protein trafficking: mechanisms and consequences. Genes Nutr 2010; 5: 129-140.
4. Chávez-Tapia NC, Uribe M, Ponciano-Rodriguez G, Medi-na-Santillán R, Méndez-Sánchez N. New insights into the pathophysiology of nonalcoholic fatty liver disease. Ann Hepatol 2009; 8(1): S9-S17.
5. García-Compean D, Jaquez-Quintana JO, Maldonado-Garza H. Hepatogenous diabetes. Current views of an ancient problem. Ann Hepatol 2009; 8(1): 13-20.
6. Del Campo JA, Romero-Gómez M. Steatosis and insulin resistance in hepatitis C: A way out of the virus? World J Gastroenterol 2009; 15(40): 5016-5019.
7. Dienstang JL, Isselbacher KJ. Acute viral hepatitis. In: Kasper DL, Braunwald E, Fauci AS, et al. (eds.). Harrison's Principles of Internal Medicine. 16th Ed. New York, USA: McGraw-Hill; 2005, p.1825-1855.
8. CENAVECE Epidemiología, dirección general de epidemiolo-gía. Available at http://www.dgepi.salud.gob.mx/anuarios.
9. Méndez-Sánchez N, Chávez-Tapia NC, Zamora-Valdés D, Medina-Santillán R, Uribe M. Hepatobilliary diseases and insulin resistance. Curr Med Chem 2007; 14(18): 1988-1999.
10. Almeda-Valdés P, Cuevas-Ramos D, Aguilar-Salinas CA. Metabolic syndrome and non-alcoholic fatty liver disease. Ann Hepatol 2009; 8(1): S18-S24.
11. Flores-Calderón J, Gómez-Díaz RA, Rodríguez-Gómez G, Morán-Villota S. Frequency of increased aminotransfera-ses levels and associated metabolic abnormalities in obese and overweight children of an elementary school in Mexico City. Ann Hepatol 2005; 4(4): 279-283.
12. Encuesta Nacional de Salud 2006. Available at http://www.todoendiabetes.org/diabe2/pdf/ensanut2006.pdf.
13. Méndez-Sánchez N, Aguilar-Ramírez JR, Reyes A, et al. Etiology of liver cirrhosis in Mexico. Ann Hepatol 2004; 3(1): 30-33.
14. Méndez-Sánchez N, Villa AR, Vázquez-Elizondo G, Poncia-no-Rodríguez G, Uribe M. Mortality trends for liver cancer in Mexico from 2000 to 2006. Ann Hepatol 2008; 7(3): 226-229.
15. Encuesta Nacional de Adicciones. 2008. Available at www.conadic.salud.gob.mx/pdfs/ena08/ENA08_NACIONAL.pdf
16. Kim WR, Brown RS Jr, Terrault NA, El-Serag H. Burden of liver disease in the United States: summary of a workshop. Hepatology 2002; 36: 227-242.
17. Norton R, Batey R, Dwyer T, MacMahon S. Alcohol consumption and the risk of alcohol related cirrhosis in women. Br Med J (Clin res Ed) 1987; 295: 80-82.
18. Mendez-Sánchez N, Almeda-Valdés P, Uribe M. Alcoholic liver disease. An update. Ann Hepatol 2005; 4(1): 32-42.
19. Shaheen M, Echeverry D, Garcia OM, et al. Hepatitis C, metabolic syndrome, and inflammatory markers: Results from the Third National Health and Nutrition Examination Survey [NHANES III]. Diabetes Res Clin Pract 2007; 75: 320-326.
20. Valdespino JL, Conde-González CJ, Olaíz-Fernández G, Kerchenobich D, Sepúlveda J. Seroprevalencia de la hepatitis C en adultos de México: ¿un problema de salud públi-ca emergente? Salud Publica Mex 2007; 49(Suppl. 3): S395-S403.
21. González-Huezo MS, Sánchez-Hernández E, Camacho MC. Prevalencia de marcadores posituvos para hepatitis B(Ags-VHB) y hepatitis C (Anti-VHC) en personal de salud del IS-SEMYM (Instituto de Seguridad Social del Estado de México y municipios). Rev Gastroenterol Mex 2010; 75(3): 4-11.
22. Valdespino JL, Conde-González CJ, Olaiz-Fernández G, Pal-ma O, Sepúlveda J. Prevalencia en México de la infección y el estado de portador de la hepatitis B en adultos. Salud Publica Mex 2007; 49(Suppl. 3): S404-S411.
23. Latin American Association for the Study of the Liver Practice Guidelines. Diagnosis, management, and treatment of hepatitis C. Ann Hepatol 2010; 9(Suppl. 1): S8-S26.
24. Méndez-Sánchez N, Gutiérrez-Grobe Y, Kobashi-Margáin RA. Epidemiology of HCV infection in Latin America. Ann Hepatol 2010; 9(Suppl1): S27-S29.
25. Espinoza L, Hall HI, Hu X. Increases in HIV diagnosis at the US-Mexico border, 2003-2006. AIDS Education and Prevention 2009; 21(Suppl. B): 19-33.
26. Weinberg M, Waterman S, Alvarez-Lucas C, et al. The U.S.-Mexico Border Infectious disease surveillance project: establishing bi-national border surveillance. Emerging Infectious Diseases 2003; 9(1): 97-102.
27. Bosetti C, Levi F, Luccini F, et al. Worldwide mortality from cirrhosis: an update to 2002. J Hepatol 2007; 46: 827-839.
28. Narro-Robles J, Gutiérrez-Avila H, López-Cervantes M, Borges G, Rosovosky H. La mortalidad por cirrosis hepáti-ca en México I. Características epidemiológicas relevan-tes. Salud Pub Mex 1992; 34(4): 378-387.
29. Global Cancer Facts & Figures 2007. American Cancer Society. Available at http://www.cancer.org/acs/groups/content/@nho/documents/document/globalfactsandfigures2007rev2p.pdf.
30. Kew MC. Prevention of hepatocellular carcinoma. Ann He-patol 2010; 9(2): 120-132.
31. Fassio E, Díaz S, Santa C, et al. Etiology of hepatocellular carcinoma in Latin America: a prospective, multicenter, international study. Ann Hepatol 2010; 9(1): 63-69.
32. Uribe M, Gutiérrez-Grobe Y, Kobashi-Margáin RA, Mén-dez-Sánchez N. Noninvasive markers of liver fibrosis in Latin America and Mexico. Ann Hepatol 2010; 9(Suppl. 1): S43-S48.